Purchase Order HHSN269201600576P

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $9,947.04 on June 20, 2017, with completion by July 14, 2017. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no set-aside applied.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $22,474.68 on July 21, 2017, with ultimate completion by August 21, 2017. No set-aside was used. Work is performed at Bethesda, Maryland. The order is firm fixed price. Specific requirements are not detailed in the source.</p>

<p>The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $3,500.00 on June 25, 2019, with ultimate completion on September 28, 2020. Place of performance is Bethesda, Maryland. The order carries firm fixed price pricing and no set-aside designation. Specific commodity details are not disclosed in the source.</p>

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $18,430.00 on May 30, 2018, with a completion date of June 24, 2019. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis. No set-aside was used. The source does not specify the items or services procured under this order.</p>

<p>NIH Clinical Center awarded a purchase order to Illumina Inc. for $13,120.06 on July 12, 2019, with completion by July 31, 2019. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside. The specific commodity or service detail is not disclosed in the source; the award follows Illumina's established pattern of supplying sequencing instruments, reagents, consumables, and bioinformatics software to federal health and research agencies.</p>

The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $20,298.00 on July 20, 2018, with an ultimate completion date of August 1, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order procures sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product lines for DNA and RNA analysis supporting NIH research and diagnostic operations. The firm fixed price purchase order represents a...

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. valued at $4,234.06 on May 30, 2018, with an ultimate completion date of May 30, 2018. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis. No set-aside was used.</p>

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. for $19,112.76 on July 17, 2019, with an ultimate completion date of October 31, 2019. The order is a firm fixed price procurement with no set-aside. Work is performed in San Diego, California. The purchase order covers sequencing instruments, reagents, consumables, or bioinformatics software—Illumina's core product portfolio serving federal research and diagnostic agencies.</p>

The National Institutes of Health Clinical Center awarded a purchase order to Illumina, Inc. for $22,445.10 on June 12, 2019, with an ultimate completion date of September 27, 2019. No set-aside was used. Place of performance is Bethesda, Maryland. The purchase order is firm fixed price for commercial sequencing reagents, consumables, or related biotechnology products consistent with Illumina's core federal portfolio in analytical laboratory instrumentation and in vitro diagnostic substances.

<p>The NIH Clinical Center awarded a purchase order to Illumina, Inc. valued at $18,674.16 on March 15, 2018, with ultimate completion on April 16, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no small business set-aside. Specific line items or consumables are not detailed in the source.</p>